6533b7d8fe1ef96bd126aefb

RESEARCH PRODUCT

Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries.

Enrique AlborchRosa F Ruiz De ApodacaJosé A. AlabadíFrancisco J. MirandaSilvia LlorensJosé M. Centeno

subject

MaleNitroprussidemedicine.medical_specialtyArginineEndotheliumVasodilator AgentsIndomethacinProstacyclinNitric OxideNitroarginineNitric oxideDiabetes Mellitus Experimentalchemistry.chemical_compoundRenal Arterymedicine.arteryInternal medicineMedicineAnimalsRenal arteryEnzyme InhibitorsPharmacologybusiness.industryAnti-Inflammatory Agents Non-SteroidalAcetylcholineVasodilationEndocrinologymedicine.anatomical_structurechemistrycardiovascular systemSodium nitroprussideEndothelium VascularRabbitsbusinessAcetylcholinemedicine.drugArtery

description

Abstract The response of rabbit renal arteries to acetylcholine and its endothelial modulation in diabetes were investigated. Acetylcholine induced concentration-related endothelium-dependent relaxation of renal arteries that was significantly more potent in diabetic rabbits than in control rabbits. Pretreatment with NG-nitro- l -arginine ( l -NOArg), indomethacin, or l -NOArg plus indomethacin induced partial inhibition of acetylcholine-induced relaxation. Inhibition induced by l -NOArg plus indomethacin was significantly higher in arteries from diabetic rabbits than in arteries from control rabbits. In renal arteries depolarised with KCl 30 mM and incubated with l -NOArg plus indomethacin, acetylcholine-induced relaxation was almost abolished in both groups of rabbits and this response was not different from that obtained in arteries without endothelium. Sodium nitroprusside induced concentration-dependent relaxation of renal arteries from control and diabetic rabbits without significant differences between the two groups of animals. These results suggest that diabetes potentiates the acetylcholine-induced relaxation in rabbit renal arteries. Increased release of nitric oxide and prostacyclin could be responsible for the enhanced relaxant potency of acetylcholine in diabetes.

10.1016/s0014-2999(01)00832-9https://pubmed.ncbi.nlm.nih.gov/11275003